YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD

Andere talen Yunnan Botanee Bio-Technology Group Co.LTD

Aandelen

300957

CNE100004G74

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
57,51 ^CNY	-0,95%		+1,88%	-15,64%

25/04	Yunnan Botanee Bio-Technology Group Co.LTD rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
25/04	Yunnan Botanee Bio-Technology Group Co.LTD rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023	25/04
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	01/04
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.	25/03
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD	15/03
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.	13/03
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	02/01
In China's slowing beauty market, big brand discounts won't cut it	08/12
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.	06/12
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	29-10-23
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.	27-10-23
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD	27-10-23
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares.	30-08-23
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan.	30-08-23
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5%	29-08-23
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023	28-08-23
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD	09-08-23
Yunnan Botanee Seeks to Double Revenue in Three Years	14-07-23
Yunnan Botanee Bio-Technology Group Co.LTD Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 30 May 2023	24-05-23
Yunnan Botanee Bio-Technology Group Co.Ltd Announces Cash Dividend for 2022	18-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Yunnan Botanee Bio-Technology Group Co.LTD

Aandelen

300957

CNE100004G74

Andere talen

Filters